Strathclyde Institute Of Pharmacy And Biomedical Sciences

  • United Kingdom

Organization profile

Organisation profile

SIPBS is a major research centre in Scotland and is amongst the UK's top Schools of Pharmacy. We have a wide range of state-of-the-art research facilities and recently benefited from the opening of a new £36m building.

Our research is focussed on New Medicines, Better Medicines and Better Use of Medicines.

Research within the Institute is advanced through six Research Groups: 

  • Cardiovascular Research
  • Cell Biology
  • Infection, Immunity and Microbiology
  • Medicines Use and Health
  • Neuroscience
  • Pharmaceutical Sciences

We also have a number of cross-cutting Research Themes which bring together researchers from across the Institute to facilitate large-scale multidisciplinary projects. Our current themes are:

  • Cancer
  • Cardiovascular Sciences
  • Neuroscience and Mental Health

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Pharmaceutical Preparations Medicine & Life Sciences
Proteins Medicine & Life Sciences
Parasites Medicine & Life Sciences
Cells Chemical Compounds
Metabolomics Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Vaccines Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2002 2024

Research Output 1979 2019

A cost analysis of hemodialysis and peritoneal dialysis for the managment of end-stage renal failure at an academic hospital, Pretoria, South Africa

Makhele, L., Matlala, M., Sibanda, M., Martin, A. P. & Godman, B., 11 Feb 2019, (Accepted/In press) In : Pharmacoeconomics - Open. 19 p.

Research output: Contribution to journalArticle

Open Access
File
Peritoneal Dialysis
South Africa
Chronic Kidney Failure
Renal Dialysis
Costs and Cost Analysis

Activities to optimize quality and efficiency of medicines in Scotland

Godman, B., Kurdi, A., McCabe, H., MacBride-Stewart, S., Johnson, C. F., Hurding, S., Bennie, M. & Morton, A., 1 Feb 2019, (Accepted/In press). 1 p.

Research output: Contribution to conferenceAbstract

Open Access
File
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Scotland
Citalopram
Health Expenditures
Lipids

A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications

Saleem, Z., Hassali, M. A. A., Versporten, A., Godman, B., Hashmi, F. K., Goossens, H. & Saleem, F., 6 Feb 2019, (Accepted/In press) In : Expert Review of Anti-infective Therapy. 20 p.

Research output: Contribution to journalArticle

Pakistan
Anti-Bacterial Agents
Community-Acquired Infections
Ceftriaxone
Metronidazole

Prizes

2014 Laurens van Deenen Lecture

Susan Pyne (Recipient), 23 Jun 2014

Prize: Prize (including medals and awards)

2017 Science Faculty Grant Writing Challenge - overall winner

Katherine Duncan (Recipient), 2017

Prize: Prize (including medals and awards)

AAAS/Science Program for Excellence in Science

Calum Wilson (Recipient), 2016

Prize: Other distinction

Activities 1987 2019

BNA Festival of Neuroscience 2019

Susan Chalmers (Participant)
14 Apr 201917 Apr 2019

Activity: Participating in or organising an event typesParticipation in conference

Mitochondrial morphology & motility alterations with age, hyperglycaemia and amyloid

Susan Chalmers (Speaker)
16 Apr 2019

Activity: Talk or presentation typesInvited talk

Practical Python

Susan Chalmers (Participant)
19 Mar 2019

Activity: Participating in or organising an event typesParticipation in workshop, seminar, course

Impacts

Bee venom research drives industrial Drug Discovery initiative in Republic of Korea

Mark Dufton (Participant), David Watson (Participant), John Parkinson (Participant)

Impact: Impact - for External PortalEconomic and commerce, Health and welfare - new products, guidelines and services

Commercialisation of non-invasive wound monitoring system leads to quality of life benefits to patients.

Patricia Connolly (Participant), Iain Hunter (Participant)

Impact: Impact - for External PortalEconomic and commerce, Health and welfare - new products, guidelines and services

File

Economic benefit and competitive advantage from commercial adoption of an innovative non-invasive delivery method for drugs and vaccines

Katharine Carter (Participant), Valerie Ferro (Participant), Alexander Mullen (Participant), James Alexander (Participant)

Impact: Impact - for External PortalEconomic and commerce, Health and welfare - new products, guidelines and services

File